Skip to main content
Category

News Archive

umd-loh-perman-image

Wallace D. Loh: The Clash of Ideas Strengthens Our Universities—and Our Nation | TIME

By News Archive

umd-loh-perman-image

The pursuit of truth requires both free speech and racial justice

Nearly two centuries after his birth as a slave in Maryland, the great orator and abolitionist Frederick Douglass has come home. His statue, just installed at the University of Maryland, now towers over a square inscribed with his soaring words on racial justice and the transformative power of education.

Read More
cit-logo

CIT Releases 2015 Annual Report on Research Commercialization – Press Release Rocket

By News Archive

cit-logo

The Center for Innovative Technology (CIT) announced today the release of the Commonwealth Research Commercialization Fund (CRCF) annual report for FY2015, which tracks investments in high-potential technology development and commercialization initiatives throughout Virginia.

In FY2015, CIT announced 38 grants to startups, universities and research institutes engaged in research and development projects totaling $2.8 million in key sectors such as life sciences, cyber security, advanced manufacturing and energy. This investment was leveraged to secure an additional $5.6 million from private sector and university matching funds.

Read More
roche-logo

Roche breast cancer drug at centre of UK pricing row – Reuters

By News Archive

roche-logo

A Roche drug that can prolong the lives of some women with advanced breast cancer has been plunged back into the centre of a drug pricing row after Britain’s health cost agency declared that it is still too expensive.

The stand-off shows how the price of medicines is as pressing and emotive an issue in Europe as in the United States, where Democratic presidential candidate Hillary Clinton has promised to clamp down on alleged profiteering by the drug industry.

Read More
sope net logo

Calling All Healthcare and Life Science Entrepreneurs – this next SoPE Event is a Must!

By News Archive

sope-net-logo

Everything You Wanted to Know About Term Sheets But Were Afraid to Ask!

It is an entrepreneur’s dream…to receive a term sheet for your venture! Don’t let it become your nightmare by not understanding the terms or ramifications of what you are about to sign! Learn from a panel of legal and venture capital experts about what to expect, how to navigate the terminology, and what strategies you can deploy to get you the best possible deal structure. Our presenters are willing to take on your questions, from basic to the most advanced, so join us at the next National Capital SoPE Chapter meeting.

Read More
ace

Age well with Agewell Biometrics!

By News Archive

Smartphones are getting smarter thanks to Agewell Biometrics and their Equilibrium app! More specifically, Equilibrium is a “mobile software balance assessment application that allows healthcare professionals to quickly evaluate postural stability”. In turn, this can help detect signs of musculoskeletal, neurological and vestibular dysfunction in the elderly. So, in short, AgeWell Biometrics is improving senior care and quality of life by providing objective, precise and predictive fall risk assessment.

Read More

ace

nhlbi-nih-logo

NHLBI Funding & Research Opportunities and Announcements for November 16, 2015

By News Archive

nhlbi-nih-logo

Funding and Research Opportunities

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

Notices:

  • Notice of NIOSH/CDC Participation in PA-16-019 “Innovation Corps (I-Corps) at NIH Program for NIH and CDC Phase I Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grantees (Admin Supp)”
    • (NOT-CD-16-001) National Institute for Occupational Safety and Health
  • NHLBI Announces Small Business Topics of Special Interest (TOSI)
  • Notice of Correction to Award Budget in PAR-16-026 “SBIR/STTR Commercialization Readiness Pilot (CRP) Program: Technical Assistance (SB1)”

Requests for Applications:

  • NHLBI Progenitor Cell Translational Consortium (U01)
    • (RFA-HL-16-021) National Heart, Lung, and Blood Institute
    • Application Receipt Date(s): February 08, 2016
  • NHLBI Progenitor Cell Translational Consortium Coordinating Center (U24)
    • (RFA-HL-16-022) National Heart, Lung, and Blood Institute
    • Application Receipt Date(s): February 08, 2016
umd-bush-loh-image

University association declares UMD an economic development award finalist – The Diamondback : News

By News Archive

umd-bush-loh-image

The University of Maryland has been named a finalist for the Association of Public and Land-grant Universities’ Innovation & Economic Prosperity University Awards this year in recognition of its commitment to promoting regional economic development.  The advocacy association gives the awards to universities that use their resources to better society and engage their local community, according to a university news release. 

Read More
martine-rothblatt-fortune-live-media-flickr

The Oberlin Review : Off the Cuff: Martine Rothblatt, CEO and Futurist

By News Archive

martine-rothblatt-fortune-live-media-flickr

Martine Rothblatt is one of the founders of Sirius Satellite Radio and the founder and CEO of United Therapeutics, a biotechnology company. Rothblatt founded United Therapeutics in 1996 to find a cure for her daughter’s rare lung disease. In 2013, she was the highest paid female CEO in the United States. Rothblatt wrote her dissertation for her Ph.D. in medical ethics of xenotransplantation, the act of transferring cells, organs or tissues from one species to another species. She is also the founder of the Terasem Movement Foundation, a nonprofit with the stated mission of promoting the ethical use of nanotechnology for extending human life. She has written several books, including Apartheid of Sex on gender identity and Two Stars for Peace on the Israeli-Palestinian conflict. Rothblatt came out as transgender in 1994. Last Thursday, Rothblatt sat down with students from various campus media organizations for an interview before speaking in Finney Chapel as a convocation speaker.

Read More
supernus-pharmaceuticals-logo

Supernus Pharmaceuticals Announces Distribution Of Common Stock By NEA

By News Archive

supernus-pharmaceuticals-logo

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, today announced that it has received notice that, effective following the close of trading on November 11, 2015, New Enterprise Associates (NEA) distributed an aggregate of 3,820,625 shares of Supernus Pharmaceuticals common stock to its partners. “The distribution announced today is a continuation of the actions NEA took in June 2015 to distribute a portion of its position to its limited partners after holding that position for over nine years,” stated Jack Khattar, president and chief executive officer of Supernus. The NEA funds continue to hold 3,820,625 shares.

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.